Peter M. O'Callaghan, Jane McLeod, and Leon P. Pybus contributed equally to this work.
Cell line-specific control of recombinant monoclonal antibody production by CHO cells†
Article first published online: 16 APR 2010
Copyright © 2010 Wiley Periodicals, Inc.
Biotechnology and Bioengineering
Volume 106, Issue 6, pages 938–951, 15 August 2010
How to Cite
O'Callaghan, P. M., McLeod, J., Pybus, L. P., Lovelady, C. S., Wilkinson, S. J., Racher, A. J., Porter, A. and James, D. C. (2010), Cell line-specific control of recombinant monoclonal antibody production by CHO cells. Biotechnol. Bioeng., 106: 938–951. doi: 10.1002/bit.22769
- Issue published online: 29 JUN 2010
- Article first published online: 16 APR 2010
- Manuscript Accepted: 6 APR 2010
- Manuscript Revised: 1 APR 2010
- Manuscript Received: 10 DEC 2009
- BBRSC via the Bioprocessing Research Industry Club (BRIC). Grant Number: BB/E00590X/1
- Chinese hamster ovary cells;
- recombinant monoclonal antibody;
- mathematical modeling
In this study we compare the cellular control of recombinant human IgG4 monoclonal antibody (Mab) synthesis in different CHO cell lines. Based on comprehensive empirical analyses of mRNA and polypeptide synthetic intermediates we constructed cell line-specific mathematical models of recombinant Mab manufacture in seven GS-CHO cell lines varying in specific production rate (qMab) over 350-fold. This comparative analysis revealed that control of qMab involved both genetic construct and cell line-specific factors. With respect to the former, all cell lines exhibited excess production of light chain (LC) mRNA and polypeptide relative to heavy chain (HC) mediated by more rapid LC transcription and enhanced LC mRNA stability. Downstream of this, cell lines differed markedly in their relative rates of recombinant mRNA translation, Mab assembly and secretion although HC mRNA abundance and the rate of HC translation generally exerted most control over qMab—the latter being directly proportional to qMab. This study shows that (i) cell lines capable of high qMab exceed a threshold functional competency in all synthetic processes, (ii) the majority of cells in parental and transfected cell populations are functionally limited and (iii) cell engineering strategies to increase Mab production should be cell line specific. Biotechnol. Bioeng. 2010;106: 938–951. © 2010 Wiley Periodicals, Inc.